LER & CER: letter to Editor Rheumatology
The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to ‘comments and perspectives on the TREAT EARLIER study’
Q.A. Dumoulin1, A.H. Van der helm-Van mil2
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. q.a.dumoulin@lumc.nl
- Department of Rheumatology, Leiden University Medical Center, Leiden; and Department of Rheumatology, Erasmus Medical Center, Rotterdam, the Netherlands.
CER18988
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 40658493 [PubMed]
Received: 06/06/2025
Accepted : 09/06/2025
In Press: 25/06/2025
